Unity Biotechnology Inc (UBX)
NASDAQ:UBX
Holding UBX?
Track your performance easily

Unity Biotechnology (UBX) Income Statement

709 Followers

Unity Biotechnology Income Statement

Last quarter (Q2 2024), Unity Biotechnology's total revenue was $1.47M, an increase of 52.54% from the same quarter last year. In Q2, Unity Biotechnology's net income was $-5.28M. See Unity Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.92M-$ 236.00K$ 4.78M$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 3.92M-$ 236.00K$ 4.78M--
Operating Expense
$ 36.63M$ 44.67M$ 57.81M$ 61.45M$ 91.33M$ 91.00M
Operating Income
$ -36.63M$ -44.67M$ -57.57M$ -56.66M$ -91.33M$ -91.00M
Net Non Operating Interest Income Expense
$ 1.77M$ 422.00K$ -2.34M$ -3.08M$ -96.00K$ 3.29M
Other Income Expense
$ 7.44M$ 7.43M$ 1.40M$ 983.00K$ -2.41M$ 5.54M
Pretax Income
$ -29.10M$ -39.86M$ -61.31M$ -60.73M$ -93.84M$ -82.18M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -27.86M$ -39.86M$ -44.47M$ -60.73M$ -93.84M$ -82.18M
Basic EPS
$ -1.74$ -2.70$ -6.31$ 0.00$ -1.84$ -1.88
Diluted EPS
$ -1.74$ -2.70$ -6.31$ -10.90$ -1.84$ -1.88
Basic Average Shares
$ 63.96M$ 14.77M$ 9.49M$ 5.58M$ 50.86M$ 43.62M
Diluted Average Shares
$ 63.96M$ 14.77M$ 9.49M$ 5.58M$ 50.86M$ 43.62M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 36.63M$ 44.67M$ 57.81M$ 61.45M$ 91.33M$ 91.00M
Net Income From Continuing And Discontinued Operation
$ -27.86M$ -39.86M$ -44.47M$ -60.73M$ -93.84M$ -82.18M
Normalized Income
$ -7.34M---$ -91.25M$ -83.53M
Interest Expense
----$ 1.29M$ 0.00
EBIT
$ -27.39M$ -37.41M$ -57.75M$ -57.55M$ -92.55M$ -82.18M
EBITDA
$ -26.14M$ -36.23M$ -54.53M$ -52.81M$ -89.10M$ -79.51M
Currency in USD

Unity Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis